Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.55 CHF | -1.70% | -2.76% | +14.87% |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
Apr. 04 | Stocks Close in Green as Swiss Inflation Unexpectedly Slows | MT |
Sales 2024 * | 182M 199M | Sales 2025 * | 206M 225M | Capitalization | 487M 532M |
---|---|---|---|---|---|
Net income 2024 * | 23M 25.15M | Net income 2025 * | 35M 38.27M | EV / Sales 2024 * | 3 x |
Net Debt 2024 * | 57.88M 63.29M | Net Debt 2025 * | 12.51M 13.68M | EV / Sales 2025 * | 2.43 x |
P/E ratio 2024 * |
20.3
x | P/E ratio 2025 * |
17.2
x | Employees | 147 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.55% |
Latest transcript on Basilea Pharmaceutica AG
1 day | -1.70% | ||
1 week | -2.76% | ||
Current month | +7.70% | ||
1 month | +10.04% | ||
3 months | +16.02% | ||
6 months | +8.42% | ||
Current year | +14.87% |
Managers | Title | Age | Since |
---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 59 | 14-08-31 |
Adesh Kaul
DFI | Director of Finance/CFO | 50 | 08-12-31 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 60 | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicole Onetto
BRD | Director/Board Member | 71 | 17-04-26 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-12-31 |
Director/Board Member | 69 | 13-04-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 773 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 40.55 | -1.70% | 34,286 |
24-04-23 | 41.25 | +0.86% | 43,839 |
24-04-22 | 40.9 | +0.37% | 37,920 |
24-04-19 | 40.75 | -2.86% | 38,782 |
24-04-18 | 41.95 | +0.60% | 37,123 |
Delayed Quote Swiss Exchange, April 24, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.87% | 544M | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- BSLN Stock